Unravelling the Role of Plasma Fibrinogen in Acute Stroke
DOI:
https://doi.org/10.55489/njmr.14032024999Keywords:
Case-control study, Fibrinogen, Haemorrhagic stroke, Ischemic strokeAbstract
Background: A stroke is described as a sudden neurological deficit with a focused vascular origin. Atrial fibrillation, carotid stenosis, myocardial infarction, hypertension, diabetes, hyperlipidaemia, obesity, smoking and atrial myxomas are all risk factors for stroke. Stroke mortality in urban India accounts for 1% of all hospital admissions, 4% of all medical cases, and around 20% of all central nervous system illnesses. Diabetes, hypertension, smoking, and hyperlipidaemia are risk factors for stroke and have been linked to alterations in haematology and coagulation, including elevated fibrinogen levels.
Methodology: The present case-control study was conducted among 50 cases of acute stroke and 50 controls without stroke history. Plasma fibrinogen of 50 consecutive patients with acute stroke presenting to the OPD/Casualty or getting admitted to Shri Ram Murti Smark Institute of Medical Sciences was compared with 50 controls who is not suffering from stroke. An unpaired t-test was applied to compare the mean fibrinogen level of the two groups. For statistical significance p value less than 0.05 was taken with 95% confidence interval.
Result: fibrinogen level among the control group (267.0±98) was low compared to patients with overall stroke (428.8±97.8), either ischemic (470±80.5) or haemorrhagic stroke (387.6±97.6).
Conclusion: Patients with Ischemic Stroke having a mean Fibrinogen level of (508.8 mg/dL ± 74.6) and haemorrhagic stroke with 487.5±66 mean fibrinogen level had the worst outcome. There was a significant difference in mean fibrinogen levels among survival and non-survival groups of patients in ischemic and haemorrhagic stroke.
References
Farghaly WMA, El-Tallawy HN, Shehata GA, Rageh TA, Abdel-Hakeem NM, Abd Elhamed MA, et al. Epidemiology of nonfatal stroke and transient ischemic attack in Al-Kharga District, New Valley, Egypt. Neuropsychiatr Dis Treat 2013;9:1785. Doi: https://doi.org/10.2147/NDT.S48322 PMid:24273409 PMCid:PMC3836687
Murthy R, Ashok A, Kiran J. Plasma Fibrinogen Levels in Acute Stroke in Tertiary Care Hospital, Warangal. International Journal of Scientific Study 2016. https://doi.org/10.17354/ijss/2016/428.
di Minno G, Mancini M. Measuring plasma fibrinogen to predict stroke and myocardial infarction. Arteriosclerosis: An Official Journal of the American Heart Association, Inc 1990;10:1-7. Doi: https://doi.org/10.1161/01.ATV.10.1.1 PMid:2404490
Lakshmi VSS, Niveditha R. Correlation between plasma fibrinogen and acute stroke 2019. Doi: https://doi.org/10.26611/10211221
Hartman J, Frishman WH. Inflammation and atherosclerosis: A review of the role of interleukin-6 in the development of atherosclerosis and the potential for targeted drug therapy. Cardiol Rev 2014;22:147-51. Doi: Doi: https://doi.org/10.1097/CRD.0000000000000021 PMid:24618929
Samir GM; K, Osama A.; Fawzy MS; SMEM. Study of Fibrinogen Level in Acute Ischemic Stroke Patients.: Egyptian Journal of Critical Care Medicine. The Egyptian Journal of Critical Care Medicine 2020;7:51-6.
Wolberg AS. Primed to understand fibrinogen in cardiovascular disease. Arterioscler Thromb Vasc Biol 2016;36:4. Doi: https://doi.org/10.1161/ATVBAHA.115.306754 PMid:26700134 PMCid:PMC4692188
Surma S, Banach M. Fibrinogen and Atherosclerotic Cardio-vascular Diseases—Review of the Literature and Clinical Studies. International Journal of Molecular Sciences 2022, Vol 23, Page 193 2021;23:193. Doi: https://doi.org/10.3390/ijms23010193 PMid:35008616 PMCid:PMC8745133
Bots ML, Elwood PC, Salonen JT, Freire de Concalves A, Sivenius J, di Carlo A, et al. Level of fibrinogen and risk of fa-tal and non-fatal stroke. EUROSTROKE: a collaborative study among research centres in Europe. J Epidemiol Community Health (1978) 2002;56:i14-8. Doi: https://doi.org/10.1136/jech.56.suppl_1.i14 PMid:11815639 PMCid:PMC1765508
Turaj W, Słowik A, Dziedzic T, Pułyk R, Adamski M, Strojny J, et al. Increased plasma fibrinogen predicts one-year mortality in patients with acute ischemic stroke. J Neurol Sci 2006;246:13-9. Doi: https://doi.org/10.1016/j.jns.2006.01.020 PMid:16650435
Ahn HJ, Chen ZL, Zamolodchikov D, Norris EH, Strickland S. Interactions of β-Amyloid Peptide with Fibrinogen and Coagulation Factor XII may contribute to Alzheimer's Disease. Curr Opin Hematol 2017;24:427. Doi: https://doi.org/10.1097/MOH.0000000000000368 PMid:28661939 PMCid:PMC5540762
Hay JR, Johnson VE, Young AMH, Smith DH, Stewart W. Blood-Brain Barrier Disruption Is an Early Event That May Persist for Many Years After Traumatic Brain Injury in Hu-mans. J Neuropathol Exp Neurol 2015;74:1147-57. Doi: https://doi.org/10.1093/jnen/74.12.1147
Program NHBPE. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure 2004.
Committee ADAPP, ElSayed NA, Aleppo G, Bannuru RR, Bruemmer D, Collins BS, et al. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2024. Diabetes Care 2024;47:S20-42. Doi: https://doi.org/10.2337/dc24-S002 PMid:38078589
Diabetes Diagnosis & Tests | ADA n.d. https://diabetes.org/about-diabetes/diagnosis (accessed June 6, 2024).
Rizwan M, Taha Lodhi M, Maqsood A, Mukhtar Sayed T. A Study of Lipid Profile in Chronic Kidney Disease Patients. Pakistan Journal of Medical and Health Sciences 2021;15:3087-90. Doi: https://doi.org/10.53350/pjmhs211593087
Perumalla Varun Kumar A, Srinivas Reddy G, Professor A. Estimation of Plasma Fibrinogen Levels in Acute Stroke Patients 2018;06. Doi: https://doi.org/10.18535/jmscr/v6i10.129
Srinivas B, Balaji B. A Clinical Study of Plasma Fibrinogen Level in Ischemic Stroke. Int J Sci Study 2018;120. https://doi.org/ 10.17354/ijss/2018/24.
Lu M, Ye W, Adami HO, Weiderpass E. Stroke Incidence in Women under 60 Years of Age Related to Alcohol Intake and Smoking Habit. Cerebrovascular Diseases 2008;25:517-25. Doi: https://doi.org/10.1159/000131669 PMid:18480604
Shah RS, Cole JW. Smoking and stroke: the more you smoke the more you stroke. Expert Rev Cardiovasc Ther 2010;8:917. Doi: https://doi.org/10.1586/erc.10.56 PMid:20602553 PMCid:PMC2928253
Samir GM, Khalil OA, Fawzy MS, Sadek A. Study of Fibrinogen Level in Acute Ischemic Stroke Patients: Egyptian Journal of Critical Care Medicine. The Egyptian Journal of Critical Care Medicine 2020;7:51-6.
Bruno G, Cavallo-Perin P, Bargero G, Borra M, D'Errico N, Pagano G. Association of fibrinogen with glycemic control and albumin excretion rate in patients with non-insulin-dependent diabetes mellitus. Ann Intern Med 1996;125:653-7. Doi: https://doi.org/10.7326/0003-4819-125-8-199610150-00005 PMid:8849150
Giansante C, Fiotti N, Cattin L, Da Col PG, Calabrese S. Fibrin-ogen, D-dimer and thrombin-antithrombin complexes in a random population sample: relationships with other cardio-vascular risk factors. Thromb Haemost 1994;71:581-6. Doi: https://doi.org/10.1055/s-0038-1642486 PMid:8091384
Imran I, Lamsudin R, Idjradinata P, Achmad TH, Maskoen A, Wibowo S, et al. Association of β-fibrinogen promoter gene polymorphism (−148C/T), hyperfibrinogenemia and ischemic stroke in young adult patients. Egyptian Journal of Medical Human Genetics 2015;16:11-7. Doi: https://doi.org/10.1016/j.ejmhg.2014.09.004
Kofoed SC, Wittrup HH, Sillesen H, Nordestgaard BG. Fibrinogen predicts ischaemic stroke and advanced atherosclerosis but not echolucent, rupture-prone carotid plaques: the Co-penhagen City Heart Study. Eur Heart J 2003;24:567-76. Doi: https://doi.org/10.1016/S0195-668X(02)00467-0 PMid:12643890
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Shouvik Datta, Mahesh Kumar Mehrotra, Jasleen Kaur Hura
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Author/s retain the copyright of their article, with first publication rights granted to Medsci Publications.
